Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
Preferred Name | Bacampicillin | |
Synonyms |
|
|
Definitions |
A prodrug of ampicillin, a broad-spectrum, semisynthetic, beta-lactam aminopenicillin antibiotic with bactericidal activity. Bacampicillin is hydrolyzed in vivo by esterases to its active metabolite ampicillin. Ampicillin binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This interrupts bacterial cell wall synthesis and results in the weakening of the bacterial cell wall and causes cell lysis. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C65245 |
|
CAS_Registry |
50972-17-3
|
|
CHEBI_ID |
CHEBI:2968
|
|
Chemical_Formula |
C21H27N3O7S
|
|
code |
C65245
|
|
Contributing_Source |
FDA
|
|
definition |
A prodrug of ampicillin, a broad-spectrum, semisynthetic, beta-lactam aminopenicillin antibiotic with bactericidal activity. Bacampicillin is hydrolyzed in vivo by esterases to its active metabolite ampicillin. Ampicillin binds to and inactivates penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This interrupts bacterial cell wall synthesis and results in the weakening of the bacterial cell wall and causes cell lysis.
|
|
FDA_UNII_Code |
8GM2J22278
|
|
Has_Salt_Form | ||
in_subset | ||
label |
Bacampicillin
|
|
Legacy Concept Name |
Bacampicillin
|
|
Preferred_Name |
Bacampicillin
|
|
prefixIRI |
NCIT:C65245
|
|
prefLabel |
Bacampicillin
|
|
Semantic_Type |
Pharmacologic Substance
|
|
UMLS_CUI |
C0052865
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping